| Quarter | Filling ID |
|---|---|
| Q4 25 | 0002002654-26-000001 |
| Q3 25 | 0002002654-25-000006 |
| Q2 25 | 0002002654-25-000004 |
| Q1 25 | 0002002654-25-000003 |
| Q4 24 | 0002002654-25-000001 |
| Q3 24 | 0002002654-24-000005 |
| Q2 24 | 0002002654-24-000004 |
| Q1 24 | 0002002654-24-000002 |
| Q4 23 | 0002002654-24-000001 |
| Q3 23 | 0002002654-23-000008 |
| Q2 23 | 0002002654-23-000007 |
| Q1 23 | 0002002654-23-000006 |
| Q4 22 | 0002002654-23-000005 |
| Q3 22 | 0002002654-23-000004 |
| Q2 22 | 0002002654-23-000003 |
| Q1 22 | 0002002654-23-000002 |
| Q4 21 | 0002002654-23-000001 |
| Name | Title | CUSIP | Ticker | Value | Shares | Share Price | Investment | % of Portfolio |
|---|---|---|---|---|---|---|---|---|
| HORIZON THERAPEUTICS PLC | Common | G46188101 | $842,760 | 9,000,000 | SOLE | |||
| MIRATI THERAPEUTICS INC | Common | 60468T105 | $807,650 | 5,000,000 | SOLE | |||
| UNITED THERAPEUTICS CORP | Common | 91307C102 | $538,230 | 3,000,000 | SOLE | |||
| ACCELERON PHARMA INC | Common | 00434H108 | $376,470 | 3,000,000 | SOLE | |||
| ARGENX SE | Sponsored ADR | 04016X101 | $284,963 | 946,500 | SOLE | |||
| ARENA PHARMACEUTICALS INC | Common | 40047607 | $277,915 | 4,075,000 | SOLE | |||
| ASCENDIS PHARMA | Sponsored ADR | 04351P101 | $249,945 | 1,900,000 | SOLE | |||
| IOVANCE BIOTHERAPEUTICS INC | Common | 462260100 | $236,782 | 9,100,000 | SOLE | |||
| SAREPTA THERAPEUTICS INC | Common | 803607100 | $186,576 | 2,400,000 | SOLE | |||
| ALNYLAM PHARMACEUTICALS INC | Common | 02043Q107 | $170,945 | 1,150,000 | SOLE | |||
| VERTEX PHARMACEUTICALS INC | Common | 92532F100 | $159,288 | 790,000 | SOLE | |||
| MADRIGAL PHARMACEUTICALS INC | Common | 558868105 | $138,809 | 1,425,000 | SOLE | |||
| BIOMARIN PHARMACEUTICAL INC | Common | 09061G101 | $137,676 | 1,650,000 | SOLE | |||
| AMICUS THERAPEUTICS INC | Common | 03152W109 | $120,018 | 12,450,000 | SOLE | |||
| CONSTELLATION PHARMACEUTICALS INC | Common | 210373106 | $108,498 | 3,210,000 | SOLE | |||
| MERSANA THERAPEUTICS INC | Common | 59045L106 | $92,344 | 6,800,000 | SOLE | |||
| KURA ONCOLOGY INC | Common | 50127T109 | $86,319 | 4,140,000 | SOLE | |||
| XENON PHARMACEUTICALS INC | Common | 98420N105 | $67,963 | 3,650,000 | SOLE | |||
| APELLIS PHARMACEUTICALS INC | Common | 03753U106 | $66,891 | 1,245,230 | SOLE | |||
| PMV PHARMACEUTICALS INC | Common | 69353Y103 | $62,342 | 1,825,000 | SOLE | |||
| MONTE ROSA THERAPEUTICS INC | Common | 61225M102 | $62,153 | 3,311,434 | SOLE | |||
| ACADIA PHARMACEUTICALS INC | Common | 4225108 | $59,552 | 2,441,658 | SOLE | |||
| MARINUS PHARMACEUTICALS INC | Common | 56854Q200 | $58,036 | 3,235,000 | SOLE | |||
| TRILLIUM THERAPEUTICS INC | Common | 89620X506 | $55,290 | 5,700,000 | SOLE | |||
| SYNDAX PHARMACEUTICALS INC | Common | 87164F105 | $51,510 | 3,000,000 | SOLE | |||
| MANNKIND CORP | Common | 56400P706 | $47,034 | 8,630,000 | SOLE | |||
| CYMABAY THERAPEUTICS INC | Common | 23257D103 | $44,908 | 10,300,000 | SOLE | |||
| IVERIC BIO INC | Common | 46583P102 | $40,542 | 6,425,000 | SOLE | |||
| DECIPHERA PHARMACEUTICALS INC | Common | 24344T101 | $39,099 | 1,068,000 | SOLE | |||
| RELMADA THERAPEUTICS INC | Common | 75955J402 | $29,929 | 935,000 | SOLE | |||
| AVADEL PHARMACEUTICALS PLC | Sponsored ADR | 05337M104 | $29,376 | 4,365,000 | SOLE | |||
| PRAXIS PRECISION MEDICINES INC | Common | 74006W108 | $29,248 | 1,600,000 | SOLE | |||
| DESIGN THERAPEUTICS INC | Common | 25056L103 | $26,410 | 1,468,318 | SOLE | |||
| AMARIN CORP PLC | Sponsored ADR | 23111206 | $26,280 | 6,000,000 | SOLE | |||
| OLEMA PHARMACEUTICALS INC | Common | 68062P106 | $24,538 | 876,986 | SOLE | |||
| ADVERUM BIOTECHNOLOGIES INC | Common | 00773U108 | $24,325 | 6,950,000 | SOLE | |||
| MERUS N V | Common | N5749R100 | $13,906 | 660,000 | SOLE | |||
| AVIDITY BIOSCIENCES INC | Common | 05370A108 | $13,467 | 545,000 | SOLE | |||
| FENNEC PHARMACEUTICALS INC | Common | 31447P100 | $12,174 | 1,670,000 | SOLE | |||
| GENOCEA BIOSCIENCES INC | Common | 372427401 | $11,897 | 5,084,184 | SOLE | |||
| CENTESSA PHARMACEUTICALS PLC | Sponsored ADS | 152309100 | $11,105 | 500,000 | SOLE | |||
| BCTG ACQUISITION CORP | Common | 05492W103 | $9,096 | 800,000 | SOLE | |||
| ADAPTIMMUNE THERAPEUTICS PLC | Sponsored ADR | 00653A107 | $8,624 | 2,024,400 | SOLE | |||
| AERPIO PHARMACEUTICALS INC | Common | 00810B105 | $7,605 | 4,500,000 | SOLE |